Prihlásiť sa Zaregistrujte sa zadarmo

Návratnosť aktív spoločnosti Neovacs S.A

Aká je hodnota metriky Návratnosť aktív spoločnosti Neovacs S.A?

Hodnota metriky Návratnosť aktív spoločnosti Neovacs S.A. je -9.79%

Aká je definícia metriky Návratnosť aktív?



Návratnosť aktív (Return on assets - ROA) je rentabilita aktív. Vypočíta sa vydelením celkového príjmu priemerom celkových aktív.

The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.

Návratnosť aktív spoločností v sektore Health Care sektor na EURONEXT v porovnaní so spoločnosťou Neovacs S.A

Čomu sa venuje spoločnosť Neovacs S.A?

Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France.

Firmy s metrikou návratnosť aktív podobnou spoločnosti Neovacs S.A